NeuroMetrix Corp (NURO): Debts to Book Capitalization

Brandmark of NeuroMetrix Inc (NURO)

NeuroMetrix, Inc. (NURO) is currently focusing on updating the software for its Quell neurostimulator and sensors. The debt concentration level within the balance sheet capitalization clearly demonstrates the financial dynamics, with the latest figure standing at 0.01. Business development relies on the robotization of SMT lines to eliminate manual labor. Simultaneously, the company is implementing energy-efficient solutions and biodegradable packaging to comply with ESG standards.

NURO (NeuroMetrix Corporation) Debt to Book Value history from 07/04/2022 to 05/11/2025
Original product of NeuroMetrix Corporation

The ratio is calculated as the sum of all liabilities divided by the company's equity. This metric determines the business's dependence on borrowed funds and its level of financial autonomy. For NeuroMetrix, Inc. (NURO), the leverage balance is critical when scaling sales of Quell neurostimulators and diagnostic equipment. Reducing the debt load enhances investment security. The trend of financial debt relative to book capitalization clearly demonstrates the company's stability.

Who NeuroMetrix, Inc. competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value MBOT|Debt to Book Capitalization Ratio Pro-Dex Corp PDEX|Debt to Book Value Ratio Zentek Corp ZTEK|Debt to Book Value Elutia Inc. (ELUT)|milestonescientific.com - Debt to Book Capital|Debt to Book Capitalization Ratio NXGL (NEXGEL)|RVP: Debts to Net Assets|Debt to Book Capitalization Ratio Harvard Bioscience, Inc.|Femasys Corporation (FEMY) - Debt to Book Value Ratio|Debts to Book Capitalization MHUA (Meihua Medical Technologies)|Debts to Book Value Predictive Oncology Corp (POAI)|Debt to Book Value CJMB|Debts to Book Capitalization ATRI (Atrion Corp.)